These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9122990)

  • 1. Multicenter trial of the therapeutic effect of a newly developed antiplatelet agent, satigrel, on biopsy-proven chronic rejection after kidney transplantation.
    Teraoka S; Ota K; Tanabe K; Takahashi K; Toma H; Yasumura T; Yoshimura N; Oka T; Takahara S; Okuyama A; Haba T; Uchida K; Sugiyama S; Ohshima S; Sato T; Okazaki H; Morozumi K
    Transplant Proc; 1997; 29(1-2):266-71. PubMed ID: 9122990
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on xenograft rejection: the role of leukocytes and prostaglandins and their modulation by the hetrazepine WEB 2086BS.
    Saumweber DM; Bergmann R; Gokel M; Zellner C; Brecht HM; Hammer C
    Transplant Proc; 1992 Apr; 24(2):578-80. PubMed ID: 1566436
    [No Abstract]   [Full Text] [Related]  

  • 3. The involvement of platelet-activating factor in hyperacute xenogeneic rejection and its modulation by the PAF-antagonist WEB 2086BS.
    Saumweber DM; Bergmann R; Gokel M; Brecht HM; Hammer C
    Transplant Proc; 1991 Feb; 23(1 Pt 1):576-8. PubMed ID: 1990613
    [No Abstract]   [Full Text] [Related]  

  • 4. Leukotrienes during rejection after canine pancreatic allotransplantation.
    Shimizu K; Izumi R; Horichi H; Yagi M; Hashimoto T; Watanabe T; Iyobe T; Iwasa K; Ii T; Fukushima W
    Transplant Proc; 1994 Aug; 26(4):2288-9. PubMed ID: 8066752
    [No Abstract]   [Full Text] [Related]  

  • 5. Kidney graft-infiltrating cells synthesize significantly higher amounts of prostaglandin E2 pre and during acute rejection.
    Pestana M; Oliveira G; Xavier P; Mendes A; Guerra LE
    Transplant Proc; 1999; 31(1-2):306-7. PubMed ID: 10083119
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary prostanoids excretion in kidney transplantation: its relationship to acute rejection and cyclosporine-induced nephrotoxicity.
    Oppenheimer F; Hotter G; Bulbena O; Roselló-Catafau J; Gelpí E; Vilardell J; Ricart MJ; Campistol JM; Fernández-Cruz L; Carretero P
    Transplant Proc; 1994 Oct; 26(5):2606-7. PubMed ID: 7940811
    [No Abstract]   [Full Text] [Related]  

  • 7. Graft outcome in patients with biopsy-proven chronic renal allograft rejection.
    Peddi VR; Schroeder TJ; Weiskittel P; First MR
    Transplant Proc; 1999; 31(1-2):1308-9. PubMed ID: 10083584
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical evaluation of satigrel in intermittent claudicators.
    Iwai T; Qian S
    Panminerva Med; 1996 Dec; 38(4):243-8. PubMed ID: 9063033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrazolopyridine derivative acts as a novel cyclooxygenase inhibitor: antiplatelet effect in aged patients with ischemic stroke.
    Satoh K; Yoshida H; Imaizumi TA; Koyama M; Hiramoto M; Takamatsu S
    J Am Geriatr Soc; 1994 Jun; 42(6):639-42. PubMed ID: 8201150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental study on the relationship between prostaglandin production and acute pancreatic rejection.
    Hashimoto T; Izumi R; Konishi K; Yagi M; Shimizu K; Takahashi N; Takamori M; Ohhori I; Watanabe T; Yabusita K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):505-6. PubMed ID: 2495617
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial.
    Holdaas H; Jardine AG; Wheeler DC; Brekke IB; Conlon PJ; Fellstrøm B; Hammad A; Holme I; Isoniemi H; Moore R; Rowe PA; Sweny P; Talbot DA; Wadstrøm J; Østraat Ø
    Kidney Int; 2001 Nov; 60(5):1990-7. PubMed ID: 11703619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled prospective study of treatment for chronic rejection after kidney transplantation by thromboxane synthetase inhibitor.
    Teraoka S; Takahashi K; Toma H; Ota K
    Transplant Proc; 1993 Apr; 25(2):2085-6. PubMed ID: 8470279
    [No Abstract]   [Full Text] [Related]  

  • 13. Eicosanoids and delayed graft function in human renal transplantation.
    Norio K; Saareks V; Vapaatalo H; Mäkisalo H; Pere P; Lindgren L
    Transplant Proc; 2001 Jun; 33(4):2530-1. PubMed ID: 11406239
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary thromboxane B2 on allograft rejection.
    Mahoney DA; Barden AE; Vandongen R; Hurst P; Banks R; Beilin LJ; Saker B; Thatcher G
    Lancet; 1981 Nov; 2(8254):1046. PubMed ID: 6118500
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group.
    Woodle ES; Thistlethwaite JR; Gordon JH
    Transplant Proc; 1996 Dec; 28(6):3163-4. PubMed ID: 8962225
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of ligustrazine on plasma platelet aggregation rate, thromboxane B2, 6-keto-prostaglandin F1 alpha and von Willebrand's factor in patients with acute onset of cor pulmonale].
    Wang S; Xin K; Ma D
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Oct; 19(10):602-4. PubMed ID: 11783174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thiofedrine on platelet aggregation, thromboxane B2 and 6-keto-PGF1 alpha in rats.
    Qu YZ; Wang YE; Li XX
    Methods Find Exp Clin Pharmacol; 1996 Jun; 18(5):297-300. PubMed ID: 8817463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic renal allograft rejection can be predicted by the surface area under the serum creatinine versus time curve.
    Yilmaz S; Kallio E; Yilmaz A; Häyry P
    Transplant Proc; 1995 Feb; 27(1):927. PubMed ID: 7879233
    [No Abstract]   [Full Text] [Related]  

  • 19. Allogeneic heart transplantation following xenografting.
    Pratschke J; Breuer M; Hammer C; Schütz A; Kemkes BM; Engelhardt M; Brandl U; Saumweber D; Babic R; Reichart B
    Transplant Proc; 1992 Apr; 24(2):688-90. PubMed ID: 1566482
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical study of Lipo PGE1-inhibiting platelet activation in acute rejection after kidney transplantation.
    Zhang Y; Guan DL; Xia CQ; Han ZY; Xu JJ; Gao JZ; Wu KR
    Transplant Proc; 2005 Dec; 37(10):4208-10. PubMed ID: 16387079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.